Methods for treatment of cardiovascular disorders and diseases
Granted 30 Aug 2011 · 6 office actions
Current assignee: Technion Research & Development Foundation Ltd. · originally THE RAPPAPORT INSTITUTE
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Yaron Barac, Moussa B. H. Youdim, Zaid A. Abassi, Ofer Binah · Examiner: Patricia A Duffy · AU 1612 · TC 1600
Life of the patent
16 dated eventsAbstract
Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
Claims
5 · 2 independent · depth 3Classifications
3 codes- A61K31/135
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
2 priority documents›Priority documents — 2
| Type | Document | Date |
|---|---|---|
| provisional | US 60524616 | 25 Nov 2003 |
| related publication | US 20060287401 A1 | 21 Dec 2006 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock